We tested these combinations in two BRAFV600E-mutant melanoma cell lines, UCSD354L and A375-R1, which possess intrinsic and acquired resistance respectively to BRAF/MEK inhibition [9, 17, 18]. The gene discussed is MAP2K7; the disease is melanoma.